A phase I study of the CDK4/6 inhibitor, palbociclib plus 5-fluorouracil (5FU) in patients with advanced solid tumor malignancies (NCT01522989).

2016 ◽  
Vol 34 (15_suppl) ◽  
pp. 2589-2589 ◽  
Author(s):  
Michael J. Pishvaian ◽  
Hongkun Wang ◽  
Brandon George Smaglo ◽  
Jennifer Gao ◽  
Laura Macke ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumor ◽  
Phase I Study ◽  
Advanced Solid Tumor

A phase I study of intravenous artesunate in patients with advanced solid tumor malignancies

2018 ◽  
Vol 81 (3) ◽  
pp. 587-596 ◽  
Author(s):  
John F. Deeken ◽  
Hongkun Wang ◽  
Marion Hartley ◽  
Amrita K. Cheema ◽  
Brandon Smaglo ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumor ◽  
Phase I Study ◽  
Advanced Solid Tumor

scholarly journals A phase I study of liposomal-encapsulated docetaxel (LE-DT) in patients with advanced solid tumor malignancies

2012 ◽  
Vol 71 (3) ◽  
pp. 627-633 ◽  
Author(s):  
John F. Deeken ◽  
Rebecca Slack ◽  
Glen J. Weiss ◽  
Ramesh K. Ramanathan ◽  
Michael J. Pishvaian ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumor ◽  
Phase I Study ◽  
Advanced Solid Tumor

scholarly journals Phase I study of nanoliposomal irinotecan (PEP02) in advanced solid tumor patients

2015 ◽  
Vol 75 (3) ◽  
pp. 579-586 ◽  
Author(s):  
T. C. Chang ◽  
H. S. Shiah ◽  
C. H. Yang ◽  
K. H. Yeh ◽  
A. L. Cheng ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumor ◽  
Phase I Study ◽  
Advanced Solid Tumor ◽  
Tumor Patients ◽  
Nanoliposomal Irinotecan

Abstract CT016: Abexinostat (ABX) as a means to reverse pazopanib (PAZ) resistance: a phase I study in advanced solid tumor malignancies

2016 ◽  
Author(s):  
Rahul Aggarwal ◽  
Scott Thomas ◽  
Jennifer Grabowsky ◽  
Armand Harb ◽  
Jim Leng ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumor ◽  
Phase I Study ◽  
Advanced Solid Tumor
Sign in / Sign up

Export Citation Format

Share Document